Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03318341 · ClinicalTrials.gov registry record · NA
TheraBracelet Phase I
A NA study of Stroke and Cerebrovascular Accident, sponsored by TheraBracelet.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT03318341 is a NA study of Stroke and Cerebrovascular Accident that has completed, run by TheraBracelet. The registered enrollment target is 26 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03318341, a NA study of Stroke and Cerebrovascular Accident, has completed, sponsored by TheraBracelet.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This project aims to test a new technology that may improve hand function impaired from a stroke, thereby improving independence and quality of life.
Conditions Studied
Interventions
- DEVICE Sham Stimulation
- DEVICE Real Stimulation
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2018-11-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03318341
The ClinicalTrials.gov registry entry for NCT03318341 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is TheraBracelet, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Sham Stimulation is the first listed.
NCT03318341 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT03318341 about?
NCT03318341 is a clinical study titled "TheraBracelet Phase I". This project aims to test a new technology that may improve hand function impaired from a stroke, thereby improving independence and quality of life.
What is the current status of trial NCT03318341?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-01-09. Estimated completion is 2018-11-28.
What conditions does trial NCT03318341 study?
This clinical trial studies the following conditions: Stroke, Cerebrovascular Accident, Hemiparesis, Stroke Rehabilitation, Hand Function.
What interventions are being tested in trial NCT03318341?
The interventions under investigation include: Sham Stimulation (DEVICE), Real Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03318341?
This trial is sponsored by TheraBracelet, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03318341 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.